General Information of the Compound
Compound ID
CP0401398
Compound Name
7-(3-Chloro-4-fluorophenyl)-5-methyl-1,3-dihydro-H-1,4-benzodiazepin-2-one
    Show/Hide
Structure
Formula
C16H12ClFN2O
Molecular Weight
302.736
Canonical SMILES
CC1=NCC(=O)Nc2ccc(cc12)-c1ccc(F)c(Cl)c1
    Show/Hide
InChI
InChI=1S/C16H12ClFN2O/c1-9-12-6-10(11-2-4-14(18)13(17)7-11)3-5-15(12)20-16(21)8-19-9/h2-7H,8H2,1H3,(H,20,21)
    Show/Hide
InChIKey
NUKNRAGNGWQDEM-UHFFFAOYSA-N
Physicochemical Property
logP
3.9072
Rotatable Bonds
1
Heavy Atom Count
21
Polar Areas
41.46
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 136045781
ChEMBL ID
CHEMBL519560
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
IC50 = 676.7 nM
   TI
   LI
   LO
   TS